NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2021 Financial Results Conference Call
WOBURN, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its...
Day: January 21, 2022
Wound Care Commercialization to be a Key Company Focus in 2022
New video blog series part of 2022 commitment to increase and broaden communication to investorsWINNIPEG, Manitoba, Jan. 20, 2022 (GLOBE...
Yingli Pharma and MD Anderson Initiate Strategic Collaboration to Advance Development of Multiple Oncology Programs
Five-year collaboration to provide support for clinical and preclinical efforts as Yingli Pharma expands its U.S. presence with robust oncology...
China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment
TAIZHOU, China, Jan. 20, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty...
Osmind Announces Appointment of Brent Saunders, Pharma Veteran and Former CEO of Allergan, to Board of Directors
Mr. Saunders will serve on Osmind’s Board of Directors and brings decades of leadership in healthcare and life sciences, including...
Angle PLC Announces Potential in Immunotherapy Treatment Selection
PEER-REVIEWED PUBLICATION HIGHLIGHTS POTENTIAL FOR PARSORTIX SYSTEM IN IMMUNOTHERAPY TREATMENT SELECTIONParsortix isolation of CTCs highlights relationship between PD-L1 expression and...